BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2706810)

  • 1. Calcium-free dialyzate: development and applications.
    Kaye M; Barber E; Vasilevsky M; Langer K
    Clin Nephrol; 1989 Mar; 31(3):132-8. PubMed ID: 2706810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in intact parathyroid hormone levels during hemodialysis following exposure to either differing dialyzate calcium concentrations or calcium-free dialysis with varying calcium infusion rates.
    Kaye M; Fischer D
    Clin Nephrol; 1990 Aug; 34(2):84-7. PubMed ID: 2225558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate anticoagulation and dialysate with reduced buffer content in chronic hemodialysis.
    van der Meulen J; Janssen MJ; Langendijk PN; Bouman AA; Oe PL
    Clin Nephrol; 1992 Jan; 37(1):36-41. PubMed ID: 1541063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of citrate anticoagulation during plasma exchange with different replacement solutions.
    Antonic M; Gubensek J; Buturović-Ponikvar J; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):322-6. PubMed ID: 19695068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term studies using a calcium-free dialysate.
    Kaye M
    Clin Nephrol; 1993 Oct; 40(4):221-4. PubMed ID: 8261679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrate kinetics in patients receiving long-term hemodialysis therapy.
    Bauer E; Derfler K; Joukhadar C; Druml W
    Am J Kidney Dis; 2005 Nov; 46(5):903-7. PubMed ID: 16253731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load.
    Buturović-Ponikvar J; Pernat AM; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):258-61. PubMed ID: 15967002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicarbonate hemodialysis using a sorbent regenerative system.
    Richards CJ; Newhouse CE; Freeman RM
    Clin Nephrol; 1979 Jun; 11(6):289-96. PubMed ID: 477045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional citrate anticoagulation for intermittent predilution online hemofiltration.
    Gubensek J; Buturović-Ponikvar J; Skofic N; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):306-9. PubMed ID: 19695064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Length of interdialytic interval influences serum calcium and phosphorus concentrations.
    Sigrist MK; Devlin L; Taal MW; Fluck RJ; McIntyre CW
    Nephrol Dial Transplant; 2005 Aug; 20(8):1643-6. PubMed ID: 15870223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe hypercalcemia using continuous renal replacement therapy with regional citrate anticoagulation.
    Kindgen-Milles D; Kram R; Kleinekofort W; Morgera S
    ASAIO J; 2008; 54(4):442-4. PubMed ID: 18645366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional citrate anticoagulation for single-needle hemodialysis: a prospective clinical study.
    Gubensek J; Buturovic-Ponikvar J; Ponikvar R
    Blood Purif; 2007; 25(5-6):454-6. PubMed ID: 18057876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients.
    Heguilén RM; Sciurano C; Bellusci AD; Fried P; Mittelman G; Rosa Diez G; Bernasconi AR
    Nephrol Dial Transplant; 2005 Mar; 20(3):591-7. PubMed ID: 15687112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
    Rudnicki M; Frølich A; Haaber A; Tvedegaard E; Thode J
    Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of sodium levels in dialysis solutions on the distribution of total body water during hemodialysis].
    Mydlík M; Derzsiová K; Svec J; Mizla P; Takác M
    Vnitr Lek; 1989 Feb; 35(2):105-11. PubMed ID: 2711616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high bicarbonate hemodialysis on ionized calcium and risk of metastatic calcification.
    Kirschbaum B
    Clin Chim Acta; 2004 May; 343(1-2):231-6. PubMed ID: 15115701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids.
    Gabutti L; Bianchi G; Soldini D; Marone C; Burnier M
    Nephrol Dial Transplant; 2009 Mar; 24(3):973-81. PubMed ID: 18842671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional citrate anticoagulation for hemodialysis: calcium-free vs. calcium containing dialysate - a randomized trial.
    Buturovic-Ponikvar J; Cerne S; Gubensek J; Ponikvar R
    Int J Artif Organs; 2008 May; 31(5):418-24. PubMed ID: 18609515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.